Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
5/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 5 Months

13 Years 5 Months

Fund AUM

₹1107 Cr

₹8306 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.29%

0.91%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

45

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(9.42%)
  2. Ajanta Pharma Ltd(7.04%)
  3. Lupin Ltd(5.79%)
  4. Glenmark Pharmaceuticals Ltd(4.25%)
  5. Apollo Hospitals Enterprise Ltd(3.75%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(98.91%)
  2. Basic Materials(1.09%)

Health

(100%)

Equity %

98.21%

99.7%

Debt %

-

-

P/E

36.91

35.73

P/B

5.4

5.7

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-2.64%

-2.91%

3-Month Return

-2.48%

-1.77%

6-Month Return

-4.06%

-1.1%

1-Year Return

3.59%

3.24%

3-Year Return

26.58%

24.53%

5-Year Return

16.67%

16.64%

Sharpe

1.22

1.17

Alpha

0.91

0.22

Beta

0.94

0.9

Standard Deviation

15.8

15.21

Information Ratio

-0.02

-0.47

Description

UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Kamal Gada

Sailesh Raj Bhan, Lokesh Maru, Divya Sharma, Kinjal Desai

Most Popular Comparisons